Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months.

作者信息

Kang Se Hun, Kang Soo-Jin, Kim Won-Jang

机构信息

Department of Cardiology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam-si, Gyeonggi-do, Korea.

Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

出版信息

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1896-1898. doi: 10.1016/j.jcin.2017.07.018. Epub 2017 Aug 30.

DOI:10.1016/j.jcin.2017.07.018

PMID:28866035

Abstract

摘要

相似文献

Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1896-1898. doi: 10.1016/j.jcin.2017.07.018. Epub 2017 Aug 30.

Very Late Restenosis Following Bioresorbable Scaffold Implantation.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):e167-e169. doi: 10.1016/j.jcin.2017.06.015. Epub 2017 Aug 30.

Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.

Coron Artery Dis. 2016 Nov;27(7):616-7. doi: 10.1097/MCA.0000000000000391.

Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.

EuroIntervention. 2018 Feb 2;13(15):e1831-e1840. doi: 10.4244/EIJ-D-17-00051.

Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.

JACC Cardiovasc Interv. 2015 Aug 17;8(9):1264-1265. doi: 10.1016/j.jcin.2015.03.031.

In-Scaffold Neovascularization 24 Months After Bioresorbable Vascular Scaffold Implantation in a Patient With ST-Segment Elevation Myocardial Infarction.

JACC Cardiovasc Interv. 2017 Jul 10;10(13):e123-e125. doi: 10.1016/j.jcin.2017.04.031. Epub 2017 Jun 14.

Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.

EuroIntervention. 2015 Nov;11(7):746-56. doi: 10.4244/EIJY14M10_06.

In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):e7-e10. doi: 10.1016/j.jcin.2014.08.009. Epub 2014 Dec 10.

Lipid Plaque Modification During Resorption of Absorb Bioresorbable Scaffold: Insights From Optical Coherence Tomography.

JACC Cardiovasc Interv. 2018 Oct 22;11(20):2123-2124. doi: 10.1016/j.jcin.2018.06.008. Epub 2018 Sep 26.

Multiple Mechanisms in 1 In-Stent Restenosis Assessed by Optical Coherence Tomography.

JACC Cardiovasc Interv. 2017 Nov 27;10(22):2340-2341. doi: 10.1016/j.jcin.2017.07.017. Epub 2017 Nov 1.

引用本文的文献

Neoatherosclerosis　- Long-Term Assessment of Bioresorbable Vascular Scaffold.

Circ Rep. 2019 Nov 16;1(12):543-549. doi: 10.1253/circrep.CR-19-0100.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验